A big biotech company with multiple growth opportunities Keith Speights (Vertex Pharmaceuticals): Vertex Pharmaceuticals doesn't just have one path to growth. This big biotech company has multiple ...

A strong competitive advantage will help companies survive and thrive through market downturns, while those without one will struggle. We saw a big sell-off in many tech-focused growth stocks in 2022.

It is very rare to be able to buy a stock that offers both a high dividend yield and high growth. Read more to see my stock picks.

Credit Karma's revenue is up 36% to $511 million. Intuit CFO Sandeep Aujla attributed the company's growth to its integration of artificial intelligence into its flagship properties. Last July ...